Alpine Immune Sciences

IRS: 208969493

Alpine Immune Sciences Inc is a clinical-stage immunotherapy company. The company is focused on developing innovative treatments for autoimmune and inflammatory diseases. To improve the lives of patients, the group aims to create multifunctional immunotherapies through unique protein engineering technologies. Alpine has formed strategic collaborations with global biopharmaceutical companies and has a wide range of clinical and preclinical candidates in development. Its product pipeline includes ALPN-303, as well as acazicolcept (ALPN-101).

2014 (9 years)
Investor RelationsSEC
32 million (2022)

Want to see more? Sign up!